Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
PVCT US​

Provectus Biopharmaceuticals, Inc. Class A(PVCT US)

$0.05-0.004.00%Ext:$0.05-0.000.63%(Market Closed · 20:00:00 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY200012/31/2000
FY200112/31/2001
FY200212/31/2002
FY200312/31/2003
FY200412/31/2004
FY200512/31/2005
FY200612/31/2006
FY200712/31/2007
FY200812/31/2008
FY200912/31/2009
FY201012/31/2010
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-3.1-4.8-5.4-5.6
Depreciation & Amortization0.00.00.00.0
Stock Based Compensation0.01.31.21.2
Change in Working Capital0.50.10.91.8
Other Non-Cash Items0.00.0-0.00.0
Net Cash from Operating Activities-2.6-3.3-3.3-2.6
-Investments in Property, Plant & Equipment-0.0---
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities----
Net Cash from Investing Activities----
Net Debt Issuance2.22.42.22.1
Net Stock Issuance-0.30.90.2
-Net Dividends Paid----
Other Financing Activities----
Net Cash from Financing Activities2.22.73.12.3
Effect of Forex Changes-0.0-0.00.00.0
Net Change in Cash-0.4-0.5-0.2-0.2
Cash at End of Period1.00.50.31.0
Operating Cash Flow-2.6-3.3-3.3-2.6
-Capital Expenditure-0.0--0.0
Free Cash Flow-2.6-3.3-3.3-2.6